James CD - Search Results

1

The HER tyrosine kinase inhibitor CI1033 enhances cytotoxicity of 7-ethyl-10-hydroxycamptothecin and topotecan by inhibiting breast cancer resistance protein-mediated drug efflux.

Erlichman C, Boerner SA, Hallgren CG, Spieker R, Wang XY, James CD, Scheffer GL, Maliepaard M, Ross DD, Bible KC, Kaufmann SH. Erlichman C, et al. Among authors: james cd. Cancer Res. 2001 Jan 15;61(2):739-48. Cancer Res. 2001. PMID: 11212277

2

Analysis of EGF receptor amplicons reveals amplification of multiple expressed sequences.

Wang XY, Smith DI, Frederick L, James CD. Wang XY, et al. Among authors: james cd. Oncogene. 1998 Jan 15;16(2):191-5. doi: 10.1038/sj.onc.1201476. Oncogene. 1998. PMID: 9464536

3

Localization of PS6K to chromosomal region 17q23 and determination of its amplification in breast cancer.

Couch FJ, Wang XY, Wu GJ, Qian J, Jenkins RB, James CD. Couch FJ, et al. Among authors: james cd. Cancer Res. 1999 Apr 1;59(7):1408-11. Cancer Res. 1999. PMID: 10197603

4

Diversity and frequency of epidermal growth factor receptor mutations in human glioblastomas.

Frederick L, Wang XY, Eley G, James CD. Frederick L, et al. Among authors: james cd. Cancer Res. 2000 Mar 1;60(5):1383-7. Cancer Res. 2000. PMID: 10728703

5

Disruption of parallel and converging signaling pathways contributes to the synergistic antitumor effects of simultaneous mTOR and EGFR inhibition in GBM cells.

Rao RD, Mladek AC, Lamont JD, Goble JM, Erlichman C, James CD, Sarkaria JN. Rao RD, et al. Among authors: james cd. Neoplasia. 2005 Oct;7(10):921-9. doi: 10.1593/neo.05361. Neoplasia. 2005. PMID: 16242075 Free PMC article.

6

GBAS, a novel gene encoding a protein with tyrosine phosphorylation sites and a transmembrane domain, is co-amplified with EGFR.

Wang XY, Smith DI, Liu W, James CD. Wang XY, et al. Among authors: james cd. Genomics. 1998 May 1;49(3):448-51. doi: 10.1006/geno.1998.5239. Genomics. 1998. PMID: 9615231

7

Lanthionine synthetase components C-like 2 increases cellular sensitivity to adriamycin by decreasing the expression of P-glycoprotein through a transcription-mediated mechanism.

Park S, James CD. Park S, et al. Among authors: james cd. Cancer Res. 2003 Feb 1;63(3):723-7. Cancer Res. 2003. PMID: 12566319

8

3' end structure and rearrangements of EGFR in glioblastomas.

Eley G, Frederick L, Wang XY, Smith DI, James CD. Eley G, et al. Among authors: james cd. Genes Chromosomes Cancer. 1998 Nov;23(3):248-54. doi: 10.1002/(sici)1098-2264(199811)23:3<248::aid-gcc7>3.0.co;2-1. Genes Chromosomes Cancer. 1998. PMID: 9790506

9

Analysis of genomic rearrangements associated with EGRFvIII expression suggests involvement of Alu repeat elements.

Frederick L, Eley G, Wang XY, James CD. Frederick L, et al. Among authors: james cd. Neuro Oncol. 2000 Jul;2(3):159-63. doi: 10.1093/neuonc/2.3.159. Neuro Oncol. 2000. PMID: 11302336 Free PMC article.

10

Phase I study of temsirolimus in combination with EKB-569 in patients with advanced solid tumors.

Bryce AH, Rao R, Sarkaria J, Reid JM, Qi Y, Qin R, James CD, Jenkins RB, Boni J, Erlichman C, Haluska P. Bryce AH, et al. Among authors: james cd. Invest New Drugs. 2012 Oct;30(5):1934-41. doi: 10.1007/s10637-011-9742-1. Epub 2011 Sep 1. Invest New Drugs. 2012. PMID: 21881915 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

370 results

Search Page

Filters